Bing

The stock price of Biogen increased more than 3% to $302.29 per ... Last month, they filed IPR petitions against the patents held bu Hoffman-La Roche, Bristol-Myers, and Aegerion. Kyle Bass accused of abusing …
Value Walk · ByMarie Cabural · 1 day ago
First, let me say that we are in blast zone mode, meaning the stock market is trying to reassess, once again, the impact of China's slowing economy on the world and on our stocks. It is not trying to figure out how China impacts sales of Bristol-Myers ...
realmoney.thestreet.com · ByJim Cramer · 8/12/2015
Celldex (NASDAQ: CLDX) and Bristol-Myers (NYSE ... we think the combination of varlilumab and nivolumab could play an important role in maximizing the body’s immune response to cancer.” [Updated with stock movement] Celldex shares were up …
Xconomy · 5/14/2014
UnitedHealth has outperformed the broader stock ... Myers Squibb (BMY), beat the market last year. It is up so far in 2015 while the S&P 500 is down. Related: 2014 was a terrific year for stocks Orlando points out that for many investors, health care ...
CNN Money · ByPaul R. La · 1/21/2015
Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Lilly, Medtronic, Otsuka, Pfizer, Roche, Sanofi, Servier, Takeda, the Medicines Company, and Vivus and holds stock in Aterovax. European Society of Cardiology …
Medscape News · 1 day ago
One of Isaly's holdings is Bristol-Meyers Squibb (BMY), which lists some 40 new drugs in exploratory ... And many big drug companies have low stock prices, relative to earnings, says Mark Oelschlager, manager of Live Oak Health Sciences.
usatoday30.usatoday.com · ByJohn Waggoner · 2/17/2012
The stock rallied 4.6 percent intraday (in addition to 3 percent ... equivalent to the reference listed drug product (RLD) Baraclude tablets of Bristol-Myers Squibb. Entecavir tablets are indicated for treatment of chronic hepatitis B virus infection ...
Money Control · 8/28/2015
Bloomberg's Julie Hyman examines the stocks on the move in today's trade. She speaks on "Market Makers." Bloomberg Traders work on the floor of the New York Stock Exchange. (Photo: Richard Drew, AP) Stocks moved back into positive territory in …
USA Today · 6/17/2015
The biotechnology company agreed to buy privately-held Scioderm, which specializes in treatments for rare diseases, in a $229mln cash-and-stock deal. Bristol-Myers (NYSE:BMY) fell 2% to $59.40, erasing an earlier …
Proactiveinvestors · 8/31/2015
Allied Minds listed on the London Stock Exchange in June 2014 ... "We have created six new subsidiaries, formed a historic joint venture with Bristol-Myers Squibb, attracted USD75.2 million in third party investment for subsidiary acceleration, and ...
London South East · 8/27/2015

Bristol-Myers Squibb

Company
Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-M…
Bristol-Myers Squibb, often referred to as BMS, is an American pharmaceutical company, headquartered in New York City. Bristol-Myers Squibb manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders. Its mission is to "discover, develop and deliver innovative medicines that help patients prevail over serious diseases."
Data from: Wikipedia · Freebase